Clinical study of the effect of the preparation deodan on leukopenia, induced by cytostatics
- 1 September 1997
- journal article
- clinical trial
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 19 (9-10) , 487-492
- https://doi.org/10.1016/s0192-0561(97)00080-5
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Stimulating effect of deodan (an oral preparation from Lactobacillus bulgaricus “LB51”) on monocytes/ macrophages and host resistance to experimental infectionsInternational Journal of Immunopharmacology, 1993
- Determination of cytokine release after in vivo and in vitro administration of deodan (a preparation from Lactobacillus bulgaricus “LB51”) by the rabbit pyrogen testInternational Journal of Immunopharmacology, 1992
- Endogenous production of tumor necrosis factor in normal mice orally treated with deodan — A preparation from Lactobacillus bulgaricus “LB51”International Journal of Immunopharmacology, 1992
- Oral administration of a streptococcal agent OK-432 activates peritoneal macrophages in miceInternational Journal of Immunopharmacology, 1991
- Assay of Pyrogens by Interleukin-6 Release from Monocytic Cell LinesJournal of Pharmacy and Pharmacology, 1991
- Effect of orally administered β-glucan on macrophage function in miceInternational Journal of Immunopharmacology, 1990
- Structure, design, and synthesis of immunoactive peptidesPublished by Walter de Gruyter GmbH ,1987
- ANTI-TUMOUR THERAPY BY INDUCTION OF ENDOGENOUS TUMOUR NECROSIS FACTORThe Lancet, 1985
- Antitumour glycopeptides from Lactobacillus bulgaricus cell wallFEBS Letters, 1975